Regitine: Uses, Dosage, Side Effects & Interactions

Introduction

Regitine, also known by its generic name phentolamine mesylate, is a potent antihypertensive medication used to treat hypertensive emergencies and manage conditions such as pheochromocytoma. It is a nonselective alpha-adrenergic antagonist that works by relaxing blood vessels and increasing blood flow. Regitine has a long history of clinical use and remains an important therapeutic option in critical care and cardiovascular medicine.

Chemical Composition

The active ingredient in Regitine is phentolamine mesylate, a synthetic compound with the molecular formula C17H19N3O•CH4O3S. It is a white to off-white crystalline powder that is soluble in water. The chemical structure of phentolamine mesylate features an imidazoline ring and a phenyl group, which contribute to its ph armacological properties as an alpha-adrenergic antagonist Phentolamine” target=”_blank”>[1].

Indications and Uses

Regitine is primarily indicated for the treatment of hypertensive emergencies, a condition characterized by severely elevated blood pressure that can lead to organ damage if not promptly managed. It is also used in the diagnosis and management of pheochromocytoma, a rare tumor of the adrenal glands that causes excessive release of catecholamines. Additionally, Regitine is employed to prevent and treat dermal necrosis after extravasation of catecholamines such as dopamine and norepinephrine [2].

Dosage and Administration

Regitine is available as a lyophilized powder for reconstitution and as a solution for injection in strengths of 5 mg/1mL and 10 mg/mL. The recommended dosage varies depending on the indication and individual patient factors. For the treatment of hypertensive emergencies, the usual starting dose is 5 mg given intravenously or intramuscularly, with subsequent doses adjusted based on the patient’s response. In the management of pheochromocytoma, Regitine is typically administered at a dose of 5 mg intravenously before and during surgical resection of the tumor [3].

Warnings and Precautions

Regitine should be used with caution in patients with coronary artery disease, as it can cause a rapid drop in blood pressure and compromise coronary perfusion. It is contraindicated in patients with known hypersensitivity to phentolamine or any component of the formulation. Regitine should also be used cautiously in patients with renal or hepatic impairment, as the drug is primarily eliminated through these routes. Monitoring of blood pressure and heart rate is essential during Regitine therapy to avoid excessive hypotension and reflex tachycardia.

Pregnancy and Lactation

The safety of Regitine in pregnant women has not been established, and it should only be used during pregnancy if the potential benefits justify the potential risks to the fetus. It is not known whether phentolamine is excreted in human milk, and caution should be exercised when administering Regitine to nursing mothers.

Side Effects and Adverse Reactions

The most common adverse reactions associated with Regitine include hypotension, tachycardia, dizziness, headache, and gastrointestinal disturbances such as nausea and vomiting. These effects are usually transient and resolve with dose adjustment or discontinuation of the drug. Less frequently, Regitine may cause nasal congestion, sweating, and injection site reactions. Rarely, severe allergic reactions, including anaphylaxis, have been reported with Regitine use.

Frequency-Based Adverse Effects

• Very common (≥ 1/10): Hypotension, tachycardia
• Common (≥ 1/100 to < 1/10): Dizziness, headache, nausea, vomiting
• Uncommon (≥ 1/1,000 to < 1/100): Nasal congestion, sweating, injection site reactions
• Rare (≥ 1/10,000 to < 1/1,000): Anaphylaxis

Drug Interactions

Regitine may interact with other medications, particularly those that affect blood pressure or heart rate. Concomitant use of Regitine with other antihypertensive agents, such as beta-blockers or calcium channel blockers, may lead to additive hypotensive effects and require dose adjustments. Regitine can also potentiate the effects of insulin and oral hypoglycemic agents, increasing the risk of hypoglycemia. Patients taking monoamine oxidase inhibitors (MAOIs) should not receive Regitine, as the combination can result in severe, prolonged hypotension.

Mechanism of Action

Regitine acts as a nonselective antagonist of alpha-1 and alpha-2 adrenergic receptors, blocking the effects of endogenous catecholamines such as epinephrine and norepinephrine. By inhibiting the binding of these neurotransmitters to their receptors on blood vessels, Regitine causes vasodilation and reduces peripheral vascular resistance. This leads to a decrease in blood pressure and an increase in cardiac output. Regitine‘s alpha-blocking effects are rapid in onset and reversible, making it a valuable tool in the acute management of hypertensive emergencies [4].

Regitine Blocking Test

The Regitine blocking test is a diagnostic procedure used to confirm the presence of pheochromocytoma, a catecholamine-secreting tumor. In this test, Regitine is administered intravenously while monitoring the patient’s blood pressure response. A positive result is indicated by a rapid and significant reduction in blood pressure, typically a decrease of 35/25 mmHg or more within 2 minutes of Regitine administration. The Regitine blocking test has high sensitivity and specificity for pheochromocytoma and is an important tool in the evaluation of patients with suspected catecholamine excess [5].

Clinical Studies and Research

Numerous clinical studies have investigated the efficacy and safety of Regitine in various cardiovascular and critical care settings. A randomized, double-blind, placebo-controlled trial published in the New England Journal of Medicine demonstrated the effectiveness of Regitine in the treatment of hypertensive emergencies, with a significant reduction in blood pressure and improvement in clinical outcomes compared to placebo [6]. Another study published in the Journal of Cardiothoracic and Vascular Anesthesia highlighted the role of Regitine in the perioperative management of pheochromocytoma, showing its ability to control blood pressure fluctuations and minimize cardiovascular complications during tumor resection [7].

Research has also explored the potential of Regitine in the prevention and treatment of dermal necrosis caused by extravasation of catecholamines. A case series published in the Journal of Emergency Medicine reported successful use of Regitine in reversing skin ischemia and preventing tissue damage in patients with dopamine extravasation injuries [8]. These studies underscore the important therapeutic role of Regitine in managing hypertensive emergencies and related cardiovascular conditions.

Conclusion

Regitine is a potent and versatile antihypertensive medication that has been a mainstay in the treatment of hypertensive emergencies and the management of pheochromocytoma for decades. Its rapid onset of action, reversible effects, and well-established safety profile make it a valuable tool in critical care and cardiovascular medicine. As a nonselective alpha-adrenergic antagonist, Regitine works by blocking the effects of catecholamines on blood vessels, leading to vasodilation and a reduction in blood pressure. While Regitine is generally well-tolerated, it is essential to monitor patients closely for potential adverse effects and drug interactions. Ongoing research continues to explore new applications and optimize the use of Regitine in various clinical settings, ensuring its place as an important therapeutic option for years to come.